Position in JNJ
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$24,188,356
+$7,611,413 QoQ
Shares Held
95,241
+40.4% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.44%
of 13F equity value
Holder Rank
#664
of 4,676 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 67%
Shared 0%
None 33%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026FLPUTNAM INVESTMENT MANAGEMENT CO holds $264,283,617 across 13 Drug Manufacturers - General names. JNJ ranks #5 (9.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
88,942 | $106,679,711 | |
| 2 | MRK |
Merck & Co., Inc.
|
248,349 | $31,912,846 | |
| 3 | AZN |
Astrazeneca PLC
|
142,906 | $27,097,835 | |
| 4 | ABBV |
AbbVie Inc.
|
105,545 | $26,559,343 | |
| 5 | JNJ |
Johnson & Johnson
This page
|
95,241 | $24,188,356 | |
| 6 | AMGN |
Amgen Inc
|
56,484 | $20,453,986 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
236,011 | $13,598,953 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
70,944 | $8,963,064 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $24,188,356 | 95,241 | Shares | Sole | 2026-08-06 | |
| 2026-03-31 | $16,576,943 | 67,816 | Shares | Sole | 2026-05-05 | |
| 2025-12-31 | $13,922,768 | 67,276 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $12,090,681 | 65,207 | Shares | Sole | 2025-10-10 | |
| 2025-06-30 | $11,455,486 | 74,995 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $14,095,570 | 84,995 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $14,428,882 | 99,771 | Shares | Sole | 2025-02-05 | |
| 2024-09-30 | $29,815,960 | 183,981 | Shares | Sole | 2024-11-08 | |
| 2024-06-30 | $15,390,648 | 105,300 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $8,982,344 | 56,782 | Shares | Sole | 2024-05-03 | |
| 2023-12-31 | $9,420,230 | 60,101 | Shares | Sole | 2024-01-30 | |
| 2023-09-30 | $9,379,109 | 60,219 | Shares | Sole | 2023-11-06 | |
| 2023-06-30 | $10,093,906 | 60,983 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $7,996,295 | 51,589 | Shares | Sole | 2023-04-27 | |
| 2022-12-31 | $6,653,345 | 37,664 | Shares | Sole | 2023-01-31 | |
| 2022-09-30 | $6,563,478 | 40,178 | Shares | Sole | 2022-11-07 | |
| 2022-06-30 | $6,513,551 | 36,694 | Shares | Sole | 2022-08-08 | |
| 2022-03-31 | $6,379,216 | 35,994 | Shares | Sole | 2022-04-28 | |
| 2021-12-31 | $5,863,253 | 34,274 | Shares | Sole | 2022-02-15 | |
| 2021-09-30 | $4,792,997 | 29,678 | Shares | Sole | 2021-10-26 | |
| 2021-06-30 | $4,931,821 | 29,937 | Shares | Sole | 2021-08-11 | |
| 2021-03-31 | $8,702,003 | 52,948 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $8,152,756 | 51,803 | Shares | Sole | 2021-02-02 | |
| 2020-09-30 | $10,064,288 | 67,600 | Shares | Sole | 2020-11-03 | |
| 2020-06-30 | $9,281,158 | 65,997 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $8,413,563 | 64,162 | Shares | Sole | 2020-05-08 | |
| No filing history on record for this holder in this stock. | ||||||